面向真实世界药物发现的混合量子计算流水线
A Hybrid Quantum Computing Pipeline for Real World Drug Discovery
AI总结:
本研究开发了一条混合量子计算流水线,用于解决真实药物设计中的共价键断裂与相互作用模拟问题,推动了量子计算从理论模型向实际药物发现工作流程的转化。
摘要:
量子计算凭借相较于经典方法更卓越的计算能力,有望彻底变革包括制药在内的众多科学领域。然而,量子计算在药物发现中的应用主要局限于概念验证研究,这些研究往往无法捕捉真实世界药物开发挑战的复杂性。在本研究中,我们偏离了传统研究,开发了一条量身定制的混合量子计算流水线,以解决真正的药物设计问题。我们的方法强调了量子计算在药物发现中的应用,并推动其向更具可扩展性的系统发展。我们专门构建了通用的量子计算流水线,以解决药物发现中的两个关键任务:精确测定涉及共价键断裂的前体药物活化的 Gibbs 自由能分布,以及准确模拟共价键相互作用。这项工作是基准测试量子计算在药物设计中遇到的真实场景的先驱性努力,特别是两个案例研究中都存在的共价键问题,从而实现了从理论模型到实际应用的转变。我们的结果证明了量子计算流水线集成到真实世界药物设计工作流程中的潜力。
英文摘要:
Quantum computing, with its superior computational capabilities compared to classical approaches, holds the potential to revolutionize numerous scientific domains, including pharmaceuticals. However, the application of quantum computing for drug discovery has primarily been limited to proof-of-concept studies, which often fail to capture the intricacies of real-world drug development challenges. In this study, we diverge from conventional investigations by developing \rev{a hybrid} quantum computing pipeline tailored to address genuine drug design problems. Our approach underscores the application of quantum computation in drug discovery and propels it towards more scalable system. We specifically construct our versatile quantum computing pipeline to address two critical tasks in drug discovery: the precise determination of Gibbs free energy profiles for prodrug activation involving covalent bond cleavage, and the accurate simulation of covalent bond interactions. This work serves as a pioneering effort in benchmarking quantum computing against veritable scenarios encountered in drug design, especially the covalent bonding issue present in both of the case studies, thereby transitioning from theoretical models to tangible applications. Our results demonstrate the potential of a quantum computing pipeline for integration into real world drug design workflows.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。